Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Assets (2023 - 2025)

Historic Assets for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $19.7 million.

  • Onconetix's Assets fell 6821.86% to $19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.7 million, marking a year-over-year decrease of 6821.86%. This contributed to the annual value of $28.2 million for FY2024, which is 6779.91% down from last year.
  • Per Onconetix's latest filing, its Assets stood at $19.7 million for Q3 2025, which was down 6821.86% from $19.1 million recorded in Q2 2025.
  • In the past 5 years, Onconetix's Assets ranged from a high of $87.5 million in Q4 2023 and a low of $18.8 million during Q1 2025
  • Moreover, its 3-year median value for Assets was $28.2 million (2024), whereas its average is $40.9 million.
  • As far as peak fluctuations go, Onconetix's Assets surged by 23344.26% in 2024, and later tumbled by 7497.63% in 2025.
  • Onconetix's Assets (Quarter) stood at $87.5 million in 2023, then plummeted by 67.8% to $28.2 million in 2024, then plummeted by 30.17% to $19.7 million in 2025.
  • Its last three reported values are $19.7 million in Q3 2025, $19.1 million for Q2 2025, and $18.8 million during Q1 2025.